Skip to content

To explore the application of whole process management model in health management of liver transplantation

To explore the application of whole process management model in health management of liver transplantation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080724
Enrollment
Unknown
Registered
2024-02-05
Start date
2024-02-06
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-orthotopic liver transplantation

Interventions

treatment group:Routine outpatient follow-up + full health management after liver transplantation

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Adult patients who underwent liver transplantation in our center met the diagnostic criteria for liver transplantation. He did not participate in other clinical trials and his vital signs were stable. No cognitive impairment; Patients or their family members voluntarily participated in the whole process management and signed informed consent.

Exclusion criteria

Exclusion criteria: Patients with serious diseases of heart, lung, kidney, brain, blood and other important organs; Patients with severe neurological and psychiatric diseases (such as epilepsy, depression, mania, seizures, schizophrenia, etc.); Control of unstable diabetes, hypertension, thyroid disease, etc.; Drug abuse or alcohol abuse; The investigator considered that the subjects were not suitable for this study. Participating in other clinical research trials; Cognitive impairment; Multiple organ transplantation; Liver retransplantation.

Design outcomes

Primary

MeasureTime frame
Outpatient return visit rate;readmission rate;Activities of daily living scale;Hamilton Anxiety Scale score;gross satisfaction scales;Clinical frailty Scale score;

Secondary

MeasureTime frame
VAS pain score;Timing of medical visits;Self-identity scale score;Basel immunosuppressive drug compliance assessment Scale score;Non-medical expenditure;

Countries

China

Contacts

Public ContactXie Kunlin

West China Hospital, Sichuan University

xiekun1986@163.com+86 135 1810 4060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026